Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone ...Middle East

PR Newswire - News
Innocan Pharmas Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone

HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its subsidiary, BI Sky Global (BI),...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Innocan Pharma's Subsidiary BI Sky Global Completes HRIPT Testing and Surpasses Important Sales Milestone )

    Apple Storegoogle play

    Also on site :